Indoco Remedies

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE873D01024
NSEID: INDOCO
BSEID: 532612

INR

240.90

2.6 (1.09%)

BSENSE

Dec 19

BSE+NSE Vol: 40.09 k

{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "240.90",
    "chg": 2.6,
    "chgp": "1.09%",
    "dir": 1,
    "prev_price": "238.30",
    "mcapval": "2,196.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE873D01024",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "40.09 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Technical Momentum Shifts Amid Challenging Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-technical-momentum-shifts-amid-persistent-downtrend-3759409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_technicaldot_3759409.png",
        "date": "2025-12-16 08:10:29",
        "description": "Indoco Remedies has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and evaluation adjustments. Despite a recent uptick in daily price, the pharmaceutical company’s longer-term returns continue to lag behind broader market benchmarks, underscoring the challenges faced within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Indoco Remedies Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-faces-bearish-momentum-amid-technical-downshift-3757040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_technicaldot_3757040.png",
        "date": "2025-12-12 08:05:52",
        "description": "Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a transition from a sideways trend to a bearish outlook. This article examines the latest technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current market stance."
      },
      {
        "title": "Indoco Remedies Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-forms-death-cross-signalling-potential-bearish-trend-3756630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_dealthcross_3756630.png",
        "date": "2025-12-11 18:02:02",
        "description": "Indoco Remedies, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price action over the longer term."
      },
      {
        "title": "Indoco Remedies Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-technical-momentum-shifts-amid-persistent-downtrend-3755939",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_technicaldot_3755939.png",
        "date": "2025-12-11 08:08:26",
        "description": "Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a sideways trend emerging from a previously mildly bearish stance, with technical indicators such as MACD, RSI, and moving averages providing a nuanced picture of the stock’s current positioning."
      },
      {
        "title": "Indoco Remedies Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-faces-technical-momentum-shift-amid-bearish-signals-3754688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_technicaldot_3754688.png",
        "date": "2025-12-10 08:07:17",
        "description": "Indoco Remedies has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. The pharmaceutical company’s stock price currently trades at ₹240.65, down from a previous close of ₹251.75, amid a broader market environment that has presented challenges for the sector."
      },
      {
        "title": "Why is Indoco Remedies falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indoco-remedies-fallingrising-3754293",
        "imagepath": "",
        "date": "2025-12-10 00:25:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Indoco Remedies’ stock has been under pressure in recent trading sessions, with a one-week decline of 7.73%, starkly contrasting with the Sensex’s marginal fall of 0.55%. Over the past month, the stock has lost 7.64%, while the broader market gained 1.74%. Year-to-date, the stock has plummeted 27.62%, whereas the Sensex has advanced by 8.35%. This trend extends over longer horizons as well, with the stock delivering negative returns of 24.67% over the last year and 37.78% over three years, while the Sensex posted gains of 3.87% and 36.16% respectively. Such consistent underperformance highlights investor scepticism about the company’s prospects.</p>\n<p>On 09-Dec, the stock underperformed its sector by 4.28%, hitting an intraday low..."
      },
      {
        "title": "Indoco Remedies Faces Challenging Market Assessment Amidst Financial and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-downgraded-to-strong-sell-amid-weak-financials-and-technical-setbacks-3750326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_mojoScore_3750326.png",
        "date": "2025-12-08 08:03:20",
        "description": "Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting shifts across quality, valuation, financial trends, and technical indicators. This article analyses the factors influencing the recent changes in the company’s assessment and what they imply for investors navigating a complex market environment."
      },
      {
        "title": "Indoco Remedies Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-technical-momentum-shifts-amid-mixed-market-signals-3742880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_technicaldot_3742880.png",
        "date": "2025-12-03 08:05:13",
        "description": "Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a mildly bullish trend to a sideways movement, underscoring a period of consolidation amid mixed technical indicator signals."
      },
      {
        "title": "Indoco Remedies: Analytical Perspective Shifts Amidst Challenging Financials and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-downgraded-to-sell-amid-mixed-technicals-and-weak-financials-3740211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndocoRemedies_mojoScore_3740211.png",
        "date": "2025-12-02 08:08:05",
        "description": "Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment driven by evolving technical indicators, valuation considerations, financial trends, and quality metrics. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing amid a challenging market environment."
      }
    ],
    "total": 519,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
      "datetime": "15-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "11-Dec-2025",
      "details": "Press Release regarding receipt of Establishment Inspection Report from the USFDA for the Companys API manufacturing facility located at Patalganga",
      "source": "BSE"
    },
    {
      "caption": "Retirement Of Senior Management Personnel",
      "datetime": "28-Nov-2025",
      "details": "We hereby inform you that Mr. Ajay Karajagi (President -Sales & Marketing) designated as Senior Management Personnel of the Company shall retire from the Company w.e.f close of business hours on 30-11-2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indoco Remedies Technical Momentum Shifts Amid Challenging Market Returns

2025-12-16 08:10:29

Indoco Remedies has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and evaluation adjustments. Despite a recent uptick in daily price, the pharmaceutical company’s longer-term returns continue to lag behind broader market benchmarks, underscoring the challenges faced within the Pharmaceuticals & Biotechnology sector.

Indoco Remedies Technical Momentum Shifts Amid Bearish Signals

2025-12-12 08:05:52

Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a transition from a sideways trend to a bearish outlook. This article examines the latest technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current market stance.

Indoco Remedies Forms Death Cross, Signalling Potential Bearish Trend

2025-12-11 18:02:02

Indoco Remedies, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price action over the longer term.

Indoco Remedies Technical Momentum Shifts Amid Market Challenges

2025-12-11 08:08:26

Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a sideways trend emerging from a previously mildly bearish stance, with technical indicators such as MACD, RSI, and moving averages providing a nuanced picture of the stock’s current positioning.

Indoco Remedies Technical Momentum Shifts Amid Market Challenges

2025-12-10 08:07:17

Indoco Remedies has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. The pharmaceutical company’s stock price currently trades at ₹240.65, down from a previous close of ₹251.75, amid a broader market environment that has presented challenges for the sector.

Why is Indoco Remedies falling/rising?

2025-12-10 00:25:31

Recent Price Movement and Market Performance

Indoco Remedies’ stock has been under pressure in recent trading sessions, with a one-week decline of 7.73%, starkly contrasting with the Sensex’s marginal fall of 0.55%. Over the past month, the stock has lost 7.64%, while the broader market gained 1.74%. Year-to-date, the stock has plummeted 27.62%, whereas the Sensex has advanced by 8.35%. This trend extends over longer horizons as well, with the stock delivering negative returns of 24.67% over the last year and 37.78% over three years, while the Sensex posted gains of 3.87% and 36.16% respectively. Such consistent underperformance highlights investor scepticism about the company’s prospects.

On 09-Dec, the stock underperformed its sector by 4.28%, hitting an intraday low...

Indoco Remedies Faces Challenging Market Assessment Amidst Financial and Technical Shifts

2025-12-08 08:03:20

Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting shifts across quality, valuation, financial trends, and technical indicators. This article analyses the factors influencing the recent changes in the company’s assessment and what they imply for investors navigating a complex market environment.

Indoco Remedies Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:05:13

Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a mildly bullish trend to a sideways movement, underscoring a period of consolidation amid mixed technical indicator signals.

Indoco Remedies: Analytical Perspective Shifts Amidst Challenging Financials and Mixed Technical Signals

2025-12-02 08:08:05

Indoco Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment driven by evolving technical indicators, valuation considerations, financial trends, and quality metrics. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing amid a challenging market environment.

View All News

Announcement

Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011

15-Dec-2025 | Source : BSE

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust

Announcement under Regulation 30 (LODR)-Press Release / Media Release

11-Dec-2025 | Source : BSE

Press Release regarding receipt of Establishment Inspection Report from the USFDA for the Companys API manufacturing facility located at Patalganga

Retirement Of Senior Management Personnel

28-Nov-2025 | Source : BSE

We hereby inform you that Mr. Ajay Karajagi (President -Sales & Marketing) designated as Senior Management Personnel of the Company shall retire from the Company w.e.f close of business hours on 30-11-2025.